Intuniv

Intuniv is a brand name for extended-release guanfacine hydrochloride, a medication primarily used to treat attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 17. It belongs to a class of drugs called alpha-2 adrenergic agonists. Intuniv works by affecting certain chemicals in the brain that are not balanced in people with ADHD, helping to improve attention and reduce impulsivity and hyperactivity. It is taken orally once a day.

The effectiveness of Intuniv in treating ADHD has been established in clinical trials. It is important to note that Intuniv is not a cure for ADHD but rather a treatment to help manage its symptoms. It may also be used in conjunction with other ADHD medications, such as stimulants. Side effects of Intuniv can include drowsiness, dizziness, fatigue, and a drop in blood pressure. It is crucial for patients to be monitored by a healthcare professional while taking this medication, as it can affect heart rate and blood pressure. Withdrawal from Intuniv should be gradual to avoid potential rebound effects.

Intuniv is not recommended for children under 6 years of age due to a lack of sufficient data on its safety and efficacy in this age group. The medication should be used with caution in individuals with certain medical conditions, including heart problems, liver or kidney issues, or a history of fainting. Patients should inform their doctor about all other medications they are taking, including over-the-counter drugs and herbal supplements, as these can interact with Intuniv.